Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis

Overview of attention for article published in Frontiers in Pharmacology, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 6,532 followers.

Cefdinir and beta-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis https://t.co/4HiLRwPMYj https://t.co/0N6fSNlC7E

Cefdinir and beta-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis https://t.co/IDLMBpDCT3 https://t.co/rDv4ykVIf3

Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis https://t.co/88T8pUthLI https://t.co/cdExjv2b5g

New Research: Cefdinir and β-Lactamase Inhibitor Independent Efficacy Against Mycobacterium tuberculosis https://t.co/qS5p6rlULN #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.